Optimal two-stage designs for single-arm phase II oncology trials with two binary endpoints
{{output}}
Objectives: In phase II clinical trials in oncology, the potential efficacy of a new treatment regimen is assessed in terms of anticancer activity. The standard approach consists of a single-arm two-stage design where a single bi... ...
